These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2310652)
1. The effects of a single dose of dilevalol on [3H]-noradrenaline plasma kinetics and plasma lipoprotein cholesterol concentrations. Howes LG; Rowe PR; Krum H; Louis WJ Br J Clin Pharmacol; 1990 Mar; 29(3):281-7. PubMed ID: 2310652 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects. Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352 [TBL] [Abstract][Full Text] [Related]
4. Dilevalol: a dose-response study in normal volunteers. Walden RJ; Graham BR; Liu JB; Prichard BN J Hum Hypertens; 1990 Jun; 4 Suppl 2():69-75. PubMed ID: 2196371 [TBL] [Abstract][Full Text] [Related]
5. Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits. Eisenhofer G; Cox HS; Esler MD J Auton Nerv Syst; 1991 Mar; 32(3):217-31. PubMed ID: 2037769 [TBL] [Abstract][Full Text] [Related]
6. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients. Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290 [TBL] [Abstract][Full Text] [Related]
7. Influence of beta-blockade on circulating plasma levels of 3-methoxy-4-hydroxy phenylethylene glycol (MHPG) during exercise in moderate hypertension. Drici MD; Roux M; Candito M; Rimailho A; Morand P; Lapalus P Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):807-11. PubMed ID: 1686746 [TBL] [Abstract][Full Text] [Related]
8. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man. Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912 [TBL] [Abstract][Full Text] [Related]
9. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension. Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998 [TBL] [Abstract][Full Text] [Related]
10. Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatment. Sbirrazzuoli V; Drici M; Garraffo R; Candito M; Gibelin P; Morand P; Lapalus P Drugs Exp Clin Res; 1989; 15(5):223-9. PubMed ID: 2551622 [TBL] [Abstract][Full Text] [Related]
11. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol. Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise. Bellissant E; Annane D; Thuillez C; Giudicelli JF Eur J Clin Pharmacol; 1994; 47(1):39-47. PubMed ID: 7988622 [TBL] [Abstract][Full Text] [Related]
13. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly. Clifton GG; Cook ME; Poland M; Wallin JD J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol. Donnelly R; Macphee GJ Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570 [TBL] [Abstract][Full Text] [Related]